Search details
1.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36382533
2.
Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor.
J Urol
; 208(3): 641-649, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35674780
3.
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Cancer
; 127(20): 3751-3760, 2021 10 15.
Article
in English
| MEDLINE | ID: mdl-34260067
4.
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Oncologist
; 26(2): e270-e278, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33215787
5.
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
Invest New Drugs
; 39(6): 1656-1663, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34031784
6.
Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors.
J Clin Oncol
; 41(23): 3939-3944, 2023 08 10.
Article
in English
| MEDLINE | ID: mdl-36758196
7.
Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
Clin Genitourin Cancer
; 21(4): 467-474, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37088659
8.
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 09.
Article
in English
| MEDLINE | ID: mdl-38072760
9.
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34778690
10.
Outcomes in Patients With Postchemotherapy Residual Nonretroperitoneal Disease in Nonseminomatous Germ Cell Tumors.
JAMA Oncol
; 10(1): 132-134, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-37943568
Results
1 -
10
de 10
1
Next >
>>